During the past decade, ICON Early Phase Services conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICON Early Phase Services" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Celgene" with 2 trials sponsored, "Proteostasis Therapeutics, Inc." with 2 trials sponsored, "Regulus Therapeutics Inc." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICON Early Phase Services" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "ERT: Clinical Trial Technology Solutions" with 1 trials as a collaborator, "ICON Development Solutions" with 1 trials as a collaborator, "ICON Early Phase Services" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "ICON Early Phase Services" are "Healthy Volunteers" (5 trials), "Healthy" (4 trials), "Overweight" (2 trials), "Alzheimer's Disease" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "ICON Early Phase Services" in a lesser frequency.

Most popular intervention types in "ICON Early Phase Services" are "Drug" (16 trials), "Biological" (1 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "PTI-801" (2 trials), "PTI-808" (2 trials), "CC-11050" (1 trials) and "Cohort 1 Probe Substrate Cocktail" (1 trials). Other intervention names were less common.

The vast majority of trials in "ICON Early Phase Services" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ICON Early Phase Services". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in ICON Early Phase Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ICON Early Phase Services, 17 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".